Search

everythinglearnresearchcommunity

for

Search:↓

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

NCSTN gene mutation causes abnormal skin cell differentiation and more inflammation, contributing to Hidradenitis Suppurativa.

Using a specific binding agent and low doses of FK506 can stimulate stem cells, speeding up skin healing by 25% and improving skin quality in rats and mice.

Human placenta extract reduces inflammation and symptoms in atopic dermatitis.

The hydrogel patch helps heal diabetic wounds by releasing a healing agent in response to harmful molecules and improving skin regeneration.

A teenager had both alopecia areata and vitiligo, which are rare to occur together.

17β-estradiol can reduce inflammation in the skin.

ACKR2 helps prevent skin scarring and hair loss by controlling inflammation.

CXCL7 is essential for muscle repair by aiding early neutrophil infiltration.

Finasteride helps reduce lung inflammation and damage after trauma and infection.

PRP shows promise in treating urological diseases but needs more research.

Burn injuries in mice heal similarly to humans, with inflammation and cell changes normalizing over time.

Lung immune cells can be trained to better fight infections after a virus.

Next-generation Treg therapies could help achieve lasting immune tolerance in type 1 diabetes.

Combining MMP-9 and JAK inhibitors can effectively prevent skin depigmentation in vitiligo.

Reactive lipids from aging cells change the extracellular matrix, affecting cell function and inflammation.

ILC1-like cells can cause alopecia areata by themselves.

Leukocyte recruitment is complex but crucial for resolving inflammation and developing effective therapies.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

Discoid Lupus Erythematosus causes scalp plaques that can lead to hair loss, and antimalarial drugs are effective treatments.

The study provided insights into burn healing and scarring, aiding future treatment development.

Anti-IL-1 treatments might help with certain types of hair loss in people with high inflammation.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

CXCR2 in skin cells promotes tumor growth.

Cholecystokinin may help reduce skin inflammation in psoriasis.

CXXC5 is a protein that controls cell growth and healing processes, and changes in its activity can lead to diseases like cancer and hair loss.

IL-19 and IL-24 help cells respond to DNA damage and could be targeted for cancer and age-related disease treatments.

Skin tumors with CYLD cutaneous syndrome show more NF-κB activity and less organized collagen.